false
--03-31
0002083493
0002083493
2026-01-20
2026-01-20
0002083493
XCBEU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember
2026-01-20
2026-01-20
0002083493
XCBEU:ClassOrdinarySharesParValue0.0001PerShareMember
2026-01-20
2026-01-20
0002083493
XCBEU:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareMember
2026-01-20
2026-01-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January
20, 2026
Date of Report (Date of earliest event reported)
X3
Acquisition Corp. Ltd.
(Exact
name of Registrant as specified in its charter)
| Cayman
Islands |
|
001-43061 |
|
98-1877158 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S.
Employer
Identification
Number) |
3033
Excelsior Blvd
Suite
343
Minneapolis,
MN |
|
55416 |
| (Address of Principal Executive
Offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: 612-457-0070
N/A
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act |
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act |
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act |
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Units, each consisting of
one Class A ordinary share and one-half of one redeemable warrant |
|
XCBEU |
|
The Nasdaq Stock Market
LLC |
| Class A ordinary shares,
par value $0.0001 per share |
|
XCBE |
|
The Nasdaq Stock Market
LLC |
| Warrants, each whole warrant
exercisable for one Class A ordinary share |
|
XCBEW |
|
The Nasdaq Stock Market
LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01. Entry into a Material Definitive Agreement.
On
January 20, 2026, the registration statement on Form S-1 (File No. 333-290299) (as amended, the “Registration Statement”)
relating to the initial public offering (the “IPO”) of X3 Acquisition Corp. Ltd., a Cayman Islands exempted company (the
“Company”), was declared effective by the U.S. Securities and Exchange Commission (the “SEC”).
On
January 22, 2026, the Company consummated its IPO, which consisted of 20,000,000 units (the “Units”). Each Unit consists
of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of
one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase
one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit,
generating gross proceeds to the Company of $200,000,000.
In
connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration
Statement, filed with the SEC:
| |
● |
Underwriting Agreement,
dated January 20, 2026, by and between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the underwriters
in the IPO (“Stifel”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference; |
| |
● |
Warrant Agreement, dated
January 20, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which
is attached as Exhibit 4.1 hereto and incorporated herein by reference; |
| |
● |
Letter Agreement, dated
January 20, 2026, by and among the Company, X3 Acquisition Management LLC (the “Sponsor”) and the officers and directors
of the Company, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference; |
| |
● |
Investment Management Trust
Agreement, dated January 20, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy
of which is attached as Exhibit 10.2 hereto and incorporated herein by reference; |
| |
● |
Registration Rights Agreement,
dated January 20, 2026, by and among the Company, the Sponsor and certain security holders of the Company, a copy of which is attached
as Exhibit 10.3 hereto and incorporated herein by reference; |
| |
● |
Private Placement Warrants
Purchase Agreement, dated January 20, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4
hereto and incorporated herein by reference; |
| |
● |
Indemnity Agreement, dated
January 20, 2026, by and among the Company and each of the officers and directors of the Company, a copy of which is attached as
Exhibit 10.5 hereto and incorporated herein by reference; and |
| |
● |
Administrative Services
Agreement, dated January 20, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto
and incorporated herein by reference. |
As
of January 22, 2026, a total of $200,000,000 of the net proceeds from the IPO and the Private Placement (as defined below), which amount
included $5,000,000 in deferred underwriting commissions, was deposited into a trust account established for the benefit of the Company’s
public shareholders maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest
earned on the funds in the trust account that may be released to the Company to pay its taxes and for winding up and dissolution expenses,
the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s
initial business combination, (ii) the redemption of the Company’s public shares if it is unable to complete its initial business
combination within 24 months from the closing of the IPO (or by such earlier liquidation date as the Company’s board of directors
may approve), subject to applicable law, and (iii) the redemption of the Company’s public shares properly submitted in connection
with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to modify the substance
or timing of its obligation to redeem 100% of the Company’s public shares if it has not consummated an initial business combination
within 24 months from the closing of the IPO or with respect to any other material provisions relating to shareholders’ rights
or pre-initial business combination activity.
Item
3.02. Unregistered Sales of Equity Securities.
Simultaneously
with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreement, the Company consummated a private placement
(the “Private Placement”) of an aggregate of 5,000,000 private warrants (the “Private Warrants”) to the Sponsor,
at a price of $1.00 per Private Warrant, generating total proceeds of $5,000,000. Each Private Warrant entitles the holder thereof to
purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment.
The
Private Warrants are identical to the public warrants sold as part of the Units in the IPO, except with respect to certain registration
rights and transfer restrictions, as described in the Registration Statement. Additionally, the holders of the Private Warrants agreed
not to transfer, assign or sell any of the Private Warrants or underlying securities (except in limited circumstances, as described in
the Registration Statement) until 30 days after the completion of the Company’s initial business combination. The holders of the
Private Warrants were granted certain demand and piggyback registration rights in connection with the purchase of the Private Warrants
and the underlying securities.
The
Private Warrants were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933,
as amended, as the transaction did not involve a public offering.
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On
January 20, 2026, in connection with the IPO, William N. Goetzmann, David H. Lui, Nicholas H. Smith, and Jeffry H. von Gillern were appointed
to the board of directors of the Company (the “Board”). William N. Goetzmann, David H. Lui, Nicholas H. Smith, and Jeffry
H. von Gillern are independent directors. Effective January 20, 2026, David H. Lui, Jeffry H. von Gillern and Nicholas H. Smith were
appointed to the Board’s Audit Committee (with Mr. Lui serving as chair of the Audit Committee); and William N. Goetzmann, Jeffry
H. von Gillern and Nicholas H. Smith were appointed to the Compensation Committee (with Mr. Goetzmann serving as chair of the Compensation
Committee).
Following
the appointment of William N. Goetzmann, David H. Lui, Nicholas H. Smith, and Jeffry H. von Gillern, the Board is comprised of three
classes. The term of office of the first class of directors, consisting of Chris Bemis and Jeffry H. von Gillern, will expire at the
Company’s first annual meeting of shareholders. The term of office of the second class of directors, consisting of Toby Maitland
Hudson and Nicholas H. Smith, will expire at the Company’s second annual meeting of shareholders. The term of office of the third
class of directors, consisting of Andrew J. Redleaf, William N. Goetzman and David H. Lui will expire at the Company’s third annual
meeting of shareholders.
On
January 20, 2026, in connection with their appointments to the Board, each of the members of the Board entered into the Letter Agreement
as well as an Indemnity Agreement with the Company filed, respectively, as Exhibits 10.1 and 10.5, herewith.
Other
than the foregoing, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed
as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The
foregoing descriptions of the Letter Agreement and the Indemnity Agreement do not purport to be complete and are qualified in their entireties
by reference to the Letter Agreement and Indemnity Agreement, copies of which are attached hereto as Exhibits 10.1 and 10.5, respectively,
and are incorporated herein by reference.
Item
5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.
On
January 20, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated
herein by reference. The Amended and Restated Memorandum and Articles of Association is filed herewith as Exhibit 3.1 and is incorporated
by reference herein.
Item
8.01. Other Events.
On
January 20, 2026, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to
this Current Report on Form 8-K.
On
January 22, 2026, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to
this Current Report on Form 8-K.
Item
9.01. Financial Statements and Exhibits.
| Exhibit
No. |
|
Description |
| 1.1 |
|
Underwriting Agreement, dated January 20, 2026, by and between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the underwriters |
| 3.1 |
|
Amended and Restated Memorandum and Articles of Association |
| 4.1 |
|
Warrant Agreement, dated January 20, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent |
| 10.1 |
|
Letter Agreement, dated January 20, 2026, by and among the Company, X3 Acquisition Management LLC and the officers and directors of the Company |
| 10.2 |
|
Investment Management Trust Agreement, dated January 20, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee |
| 10.3 |
|
Registration Rights Agreement, dated January 20, 2026, by and among the Company, X3 Acquisition Management LLC and certain security holders of the Company |
| 10.4 |
|
Private Placement Warrants Purchase Agreement, dated January 20, 2026, by and between the Company and X3 Acquisition Management LLC |
| 10.5 |
|
Indemnity Agreement, dated January 20, 2026, by and between the Company and each of the officers and directors of the Company |
| 10.6 |
|
Administrative Services Agreement, dated January 20, 2026, by and between the Company and X3 Acquisition Management LLC |
| 99.1 |
|
Press Release Dated January 20, 2026 |
| 99.2 |
|
Press Release Dated January 22, 2026 |
| 104 |
|
The cover page from this
Current Report on Form 8-K, formatted in Inline XBRL |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated: January 22, 2026 |
|
|
| |
|
|
| |
X3 Acquisition Corp. Ltd. |
| |
|
|
| |
By: |
/s/ Andrew
J. Redleaf |
| |
Name: |
Andrew J. Redleaf |
| |
Title: |
Chief Executive Officer |